Embedding viral hepatitis into primary healthcare: results of a strategic landscape analysis in Vietnam and the Philippines.

Autor:	Holt B; Program in Global Primary Care and Social Change, Harvard Medical School, Boston, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, USA., Fernandez M; College of Medicine, University of the Philippines, Manila, Philippines., Nguyen D; Massachusetts General Hospital, Corrigan Minehan Heart Center, Harvard Medical School, Boston, USA., Delima D; School of Health Sciences Tarlac, University of the Philippines, Tarlac, Philippines., Duy LD; The Partnership for Health Advancement in Vietnam (HAIVN), Hanoi, Vietnam.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, USA., Gaspar M; College of Medicine, University of the Philippines, Manila, Philippines., Hamoy G; College of Medicine, University of the Philippines, Manila, Philippines., Le BN; The Partnership for Health Advancement in Vietnam (HAIVN), Hanoi, Vietnam.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, USA., Llevado J; Department of Health, Disease Prevention & Control Bureau Specialty Care Division, Philippines., Manlutac JMD; Department of Health, Central Luzon Center for Health Development, Pampanga, Philippines., Mendoza J; College of Medicine, University of the Philippines, Manila, Philippines., Mercado T; College of Medicine, University of the Philippines, Manila, Philippines., Nguyen H; The Partnership for Health Advancement in Vietnam (HAIVN), Hanoi, Vietnam., Nguyen HT; The Partnership for Health Advancement in Vietnam (HAIVN), Hanoi, Vietnam.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, USA., Ong J; College of Medicine, University of the Philippines, Manila, Philippines., Rombaoa MC; School of Health Sciences Tarlac, University of the Philippines, Tarlac, Philippines., Florendo J; School of Health Sciences Tarlac, University of the Philippines, Tarlac, Philippines., Dela Cruz JM; School of Health Sciences Tarlac, University of the Philippines, Tarlac, Philippines., Pham T; The Partnership for Health Advancement in Vietnam (HAIVN), Hanoi, Vietnam.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, USA., Thai PN; Thai Binh Department of Health, Thai Binh, Vietnam., Truong PX; Thai Binh Department of Health, Thai Binh, Vietnam., Pollack T; The Partnership for Health Advancement in Vietnam (HAIVN), Hanoi, Vietnam.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, USA., Duong D; Program in Global Primary Care and Social Change, Harvard Medical School, Boston, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, USA.
Jazyk:	angličtina
Zdroj:	The Lancet regional health. Western Pacific [Lancet Reg Health West Pac] 2023 Dec 20; Vol. 44, pp. 100990. Date of Electronic Publication: 2023 Dec 20 (Print Publication: 2024).
DOI:	10.1016/j.lanwpc.2023.100990
Abstrakt:	Chronic viral hepatitis is a significant public health concern in the Western Pacific, including in Vietnam and the Philippines. To accelerate progress toward meeting the 2030 elimination goals, the World Health Organization (WHO) encourages countries to adopt an integrated, people-centered health sector response to hepatitis, grounded in Primary Health Care (PHC). A review of the academic and grey literature, along with policy documents, was conducted to describe the national health system and PHC response to hepatitis B and C in Vietnam and the Philippines. Information was analyzed against the four strategic levers of the WHO Operational Framework for PHC to identify challenges and opportunities. The findings suggest that both countries have relatively robust policy frameworks, with some room for improvement. Vietnam may have stronger political commitment and funding than the Philippines, while the Philippines appears to be stronger in community engagement. Both countries share challenges and opportunities for learning to actualize viral hepatitis elimination utilizing a PHC approach. Competing Interests: Janus Ong, Danica Dellima, and Mary Romboaoa’s institution received funding from GSK for a clinical trial on hepatitis B infection. David Duong is also a member of the World Health Organization’s Technical Advisory Group on Integrated Care Services (Primary Care) and has received travel support from them. The remaining authors have no interests to declare. No author has received any form of material compensation in relation to this material, including no consulting fees, royalties or license payments, honoraria, expert testimonies, patents, participation in leadership roles or any other activities, stocks, receipt of equipment or other gifts. (© 2023 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu